Protocol Ledger

Biopharma Industry · Consolidated Sponsor Hub

Sarepta Therapeutics: Clinical Trials & FDA Approval Profile

Sarepta Therapeutics (Global / Institutional) sponsors 15 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 6 active protocols (3 recruiting now), 3 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)40.0%
Median Closed Enrollment vs National (145 pts)29 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Sarepta Therapeutics
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)15
Active Pipeline (Recruiting Now)6 (3)
Completed vs Stopped Early3 / 6 (40.0%)
Median Closed Actual Enrollment29 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Sarepta Therapeutics
Hospital Research SiteLocationShared Protocols
Nationwide Children's HospitalColumbus, OH6
National Taiwan University HospitalTaipei5
Children's Hospital of The King's DaughtersNorfolk, VA5

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by Sarepta Therapeutics
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT05881408A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Non-Ambulatory and AmbulatorPhase IIIACTIVE NOT RECRUITING
NCT03532542An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular DystrophyPhase IIITERMINATED

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Sarepta Therapeutics across sibling Meru public-data platforms.

Explore interactive annual charts and M&A subsidiary rollups in the Sarepta Therapeutics Interactive Dossier, benchmark peers in Rare Genetic, Women's Health, and Other, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI